Stockholm - Delayed Quote SEK
Cereno Scientific AB (publ) (CRNO-B.ST)
8.00
+0.03
+(0.38%)
At close: April 25 at 5:29:38 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cost of Revenue
-86,746.70
-80,902.99
-49,276.65
-57,538.07
-44,805.36
Gross Profit
86,746.70
80,902.99
49,276.65
57,538.07
44,805.36
Operating Expense
153,335.19
156,739.15
93,926.71
84,134
59,585.63
Operating Income
-66,588.49
-75,836.16
-44,650.06
-26,595.93
-14,780.27
Net Non Operating Interest Income Expense
-14,118.70
-23,689.52
-3,456.15
-149.30
-1,244.60
Pretax Income
-81,119.01
-99,525.68
-48,106.21
-27,648.65
-16,250.68
Tax Provision
--
--
--
5.85
4.21
Net Income Common Stockholders
-81,119.01
-99,525.68
-48,106.21
-27,654.49
-16,254.89
Diluted NI Available to Com Stockholders
-81,119.01
-99,525.68
-48,106.21
-27,654.49
-16,254.89
Basic EPS
-0.31
-0.35
-0.21
-0.20
-0.15
Diluted EPS
-0.31
-0.35
-0.21
-0.20
-0.15
Basic Average Shares
266,702.06
281,701.84
185,645.04
137,514.84
105,261.78
Diluted Average Shares
266,702.06
309,158.93
228,455.69
137,514.84
105,261.78
Total Operating Income as Reported
-67,000.31
-75,836.16
-44,650.06
-27,499.35
-15,006.08
Rent Expense Supplemental
--
--
--
182.39
177.04
Total Expenses
66,588.49
75,836.16
44,650.06
26,595.93
14,780.27
Net Income from Continuing & Discontinued Operation
-81,119.01
-99,525.68
-48,106.21
-27,654.49
-16,254.89
Normalized Income
-81,119.01
-99,525.68
-48,106.21
-27,654.49
-16,254.89
Interest Income
1,844.14
2,397.37
1,840.94
309.78
1.68
Interest Expense
15,962.83
26,086.89
5,297.09
459.07
1,246.28
Net Interest Income
-14,118.70
-23,689.52
-3,456.15
-149.30
-1,244.60
EBIT
-65,156.17
-73,438.79
-42,809.12
-27,189.58
-15,004.40
EBITDA
-65,060.94
-73,151.85
-42,794.81
-27,175.27
-14,990.09
Reconciled Cost of Revenue
-86,746.70
-80,902.99
-49,276.65
-57,538.07
-44,805.36
Reconciled Depreciation
95.23
286.94
14.31
14.31
14.31
Net Income from Continuing Operation Net Minority Interest
-81,119.01
-99,525.68
-48,106.21
-27,654.49
-16,254.89
Normalized EBITDA
-65,060.94
-73,151.85
-42,794.81
-27,175.27
-14,990.09
Tax Rate for Calcs
--
--
--
0
0
12/31/2021 - 6/22/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ODI.ST ODI Pharma AB
2.5800
0.00%
SLNX Solanbridge Group, Inc.
0.0000
0.00%
MOB.ST Moberg Pharma AB (publ)
8.11
+2.47%
GSAC GelStat Corp.
0.0004
0.00%
RIPP.CN Digital Commodities Capital Corp.
0.0400
-20.00%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.3100
+4.52%
UPC Universe Pharmaceuticals INC
4.2000
+10.53%
ELTP Elite Pharmaceuticals, Inc.
0.4200
+0.02%
GELS Gelteq Limited
1.9000
-18.10%
PTPI Petros Pharmaceuticals, Inc.
0.0540
+5.47%